In the current study, we showed that Bim expression was reduced in CDDP-resistant HNSCC and exogenous administration of BDNF resulted in reduced Bim expression, a finding that is consistent with effects seen in various disease models including neuroblastoma model [18], [21]. The gene discussed is BCL2L11; the disease is neuroblastoma.